Literature DB >> 8264259

Treatment of ovarian cancer: the state of the art.

N Einhorn.   

Abstract

The state of the art in the treatment of ovarian cancer is reviewed. Development in strategies for early and advanced ovarian cancer stages as well as prospects for the future are described.

Entities:  

Mesh：

Year:  1993        PMID： 8264259     DOI： 10.1007/bf02987781

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN： 0736-0118


  23 in total

Review 1.  Ovarian cancer screening.

Authors:  T Bourne; K Reynolds; S Campbell
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer.

Authors:  V R Zurawski; K Sjovall; D A Schoenfeld; S F Broderick; P Hall; R C Bast; G Eklund; B Mattsson; R J Connor; P C Prorok
Journal:  Gynecol Oncol       Date:  1990-03       Impact factor: 5.482

Review 3.  Chemotherapy of ovarian cancer: past and present.

Authors:  R C Young
Journal:  Semin Oncol       Date:  1975-09       Impact factor: 4.929

Review 4.  Fundamental studies with cisplatin.

Authors:  B Rosenberg
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

5.  Current concepts in cancer: ovary--treatment of stages III and IV. Choice of postoperative therapy based on prognostic factors.

Authors:  A J Dembo; R S Bush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-05       Impact factor: 7.038

6.  Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.

Authors:  J R Van Nagell; P D DePriest; L E Puls; E S Donaldson; H H Gallion; E J Pavlik; D E Powell; R J Kryscio
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

7.  Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population.

Authors:  N Einhorn; B Nilsson; K Sjövall
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

8.  Primary cytoreductive surgery for epithelial ovarian cancer.

Authors:  N F Hacker; J S Berek; L D Lagasse; R K Nieberg; R M Elashoff
Journal:  Obstet Gynecol       Date:  1983-04       Impact factor: 7.661

9.  Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma.

Authors:  J T Wharton; C L Edwards; F N Rutledge
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

10.  The role of radiotherapy in ovarian cancer.

Authors:  A J Dembo
Journal:  Bull Cancer       Date:  1982       Impact factor: 1.276
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.